{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:18:07Z","timestamp":1790421487201,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T00:00:00Z","timestamp":1560988800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T00:00:00Z","timestamp":1560988800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81270602"],"award-info":[{"award-number":["81270602"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012551","name":"Applied Basic Research Program of Sichuan Province","doi-asserted-by":"publisher","award":["2018JY0044"],"award-info":[{"award-number":["2018JY0044"]}],"id":[{"id":"10.13039\/100012551","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Chengdu Science and Technology Huimin Project of China","award":["2015-HM01-00307-SF"],"award-info":[{"award-number":["2015-HM01-00307-SF"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13046-019-1280-2","type":"journal-article","created":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T09:02:31Z","timestamp":1561021351000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["A novel method to establish glucocorticoid resistant acute lymphoblastic leukemia cell lines"],"prefix":"10.1186","volume":"38","author":[{"given":"Ling","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanle","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,20]]},"reference":[{"key":"1280_CR1","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1200\/JCO.2014.59.1636","volume":"33","author":"CH Pui","year":"2015","unstructured":"Pui CH, Yang JJ, Hunger SP, Pieters R, Schrappe M, Biondi A, et al. Childhood acute lymphoblastic leukemia: Progress through collaboration. J Clin Oncol. 2015;33:2938\u201348.","journal-title":"J Clin Oncol"},{"key":"1280_CR2","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/S1470-2045(10)70114-5","volume":"11","author":"H Inaba","year":"2010","unstructured":"Inaba H, Pui CH. Glucocorticoid use in acute lymphoblastic leukaemia. Lancet Oncol. 2010;11:1096\u2013106.","journal-title":"Lancet Oncol"},{"key":"1280_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1586\/17474086.2015.978281","volume":"8","author":"F Ceppi","year":"2015","unstructured":"Ceppi F, Cazzaniga G, Colombini A, Biondi A, Conter V. Risk factors for relapse in childhood acute lymphoblastic leukemia: prediction and prevention. Expert Rev Hematol. 2015;8:57\u201370.","journal-title":"Expert Rev Hematol"},{"key":"1280_CR4","first-page":"267","volume":"88","author":"HM Coley","year":"2004","unstructured":"Coley HM. Development of drug-resistant models. Methods Mol Med. 2004;88:267\u201373.","journal-title":"Methods Mol Med"},{"key":"1280_CR5","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1097\/CAD.0b013e3280a02f43","volume":"18","author":"MB Watson","year":"2007","unstructured":"Watson MB, Lind MJ, Cawkwell L. Establishment of in-vitro models of chemotherapy resistance. Anti-Cancer Drugs. 2007;18:749\u201354.","journal-title":"Anti-Cancer Drugs"},{"key":"1280_CR6","first-page":"1174","volume":"30","author":"JL Biedler","year":"1970","unstructured":"Biedler JL, Riehm H. Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic, and cytogenetic studies. Cancer Res. 1970;30:1174\u201384.","journal-title":"Cancer Res"},{"key":"1280_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/bs.ircmb.2017.07.012","volume":"336","author":"J Starkova","year":"2018","unstructured":"Starkova J, Hermanova I, Hlozkova K, Hararova A, Trka J. Altered metabolism of leukemic cells: new therapeutic opportunity. Int Rev Cell Mol Biol. 2018;336:93\u2013147.","journal-title":"Int Rev Cell Mol Biol"},{"key":"1280_CR8","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1111\/bph.13422","volume":"173","author":"B Bhattacharya","year":"2016","unstructured":"Bhattacharya B, Mohd OMF, Soong R. The Warburg effect and drug resistance. Br J Pharmacol. 2016;173:970\u20139.","journal-title":"Br J Pharmacol"},{"key":"1280_CR9","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1186\/s12885-016-2776-1","volume":"16","author":"C Petit","year":"2016","unstructured":"Petit C, Gouel F, Dubus I, Heuclin C, Roget K, Vannier JP. Hypoxia promotes chemoresistance in acute lymphoblastic leukemia cell lines by modulating death signaling pathways. BMC Cancer. 2016;16:746.","journal-title":"BMC Cancer"},{"key":"1280_CR10","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nature13034","volume":"508","author":"JA Spencer","year":"2014","unstructured":"Spencer JA, Ferraro F, Roussakis E, Klein A, Wu J, Runnels JM, et al. Direct measurement of local oxygen concentration in the bone marrow of live animals. Nature. 2014;508:269\u201373.","journal-title":"Nature."},{"key":"1280_CR11","first-page":"3865","volume":"43","author":"R Zawydiwski","year":"1983","unstructured":"Zawydiwski R, Harmon JM, Thompson EB. Glucocorticoid-resistant human acute lymphoblastic leukemic cell line with functional receptor. Cancer Res. 1983;43:3865\u201373.","journal-title":"Cancer Res"},{"key":"1280_CR12","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO;2-J","volume":"18","author":"GE Foley","year":"1965","unstructured":"Foley GE, Lazarus H, Faraber S, Uzman BG, Boone BA, Mccarthy RE. Continous culture of human lymphoblasts from peripheral blood of a child with acute leukemia. Cancer. 1965;18:522\u20139.","journal-title":"Cancer."},{"key":"1280_CR13","doi-asserted-by":"publisher","first-page":"235","DOI":"10.5045\/br.2015.50.4.235","volume":"50","author":"AM Bedewy","year":"2015","unstructured":"Bedewy AM, El-Maghraby SM, Kandil NS, El-Bendary WR. The prognostic value of glucocorticoid receptors for adult acute lymphoblastic leukemia. Blood Res. 2015;50:235\u201341.","journal-title":"Blood Res"},{"key":"1280_CR14","first-page":"4857","volume":"41","author":"CD Bloomfield","year":"1981","unstructured":"Bloomfield CD, Smith KA, Peterson BA, Munck A. Glucocorticoid receptors in adult acute lymphoblastic leukemia. Cancer Res. 1981;41:4857\u201360.","journal-title":"Cancer Res"},{"key":"1280_CR15","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13046-015-0221-y","volume":"34","author":"GJ Yoshida","year":"2015","unstructured":"Yoshida GJ. Metabolic reprogramming: the emerging concept and associated therapeutic strategies. J Exp Clin Cancer Res. 2015;34:111.","journal-title":"J Exp Clin Cancer Res"},{"key":"1280_CR16","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1038\/leu.2011.46","volume":"25","author":"AM Martelli","year":"2011","unstructured":"Martelli AM, Evangelisti C, Chappell W, Abrams SL, B\u00e4secke J, Stivala F, et al. Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K\/PTEN\/Akt\/mTOR pathway. Leukemia. 2011;25:1064\u201379.","journal-title":"Leukemia."},{"key":"1280_CR17","doi-asserted-by":"publisher","first-page":"6440","DOI":"10.1002\/jcp.26539","volume":"233","author":"C Simioni","year":"2018","unstructured":"Simioni C, Martelli AM, Zauli G, Vitale M, McCubrey JA, Capitani S, et al. Targeting the phosphatidylinositol 3-kinase\/Akt\/mechanistic target of rapamycin signaling pathway in B-lineage acute lymphoblastic leukemia: an update. J Cell Physiol. 2018;233:6440\u201354.","journal-title":"J Cell Physiol"},{"key":"1280_CR18","first-page":"1681","volume":"8","author":"S Greenstein","year":"2002","unstructured":"Greenstein S, Ghias K, Krett NL, Rosen ST. Mechanisms of glucocorticoid-mediated apoptosis in hematological malignancies. Clin Cancer Res. 2002;8:1681\u201394.","journal-title":"Clin Cancer Res"},{"key":"1280_CR19","doi-asserted-by":"publisher","first-page":"4971","DOI":"10.1182\/blood-2011-11-389957","volume":"119","author":"Y Chen","year":"2012","unstructured":"Chen Y, Jacamo R, Shi YX, Wang RY, Battula VL, Konoplev S, et al. Human extramedullary bone marrow in mice: a novel in vivo model of genetically controlled hematopoietic microenvironment. Blood. 2012;119:4971\u201380.","journal-title":"Blood."},{"key":"1280_CR20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3389\/fonc.2016.00041","volume":"6","author":"M Deynoux","year":"2016","unstructured":"Deynoux M, Sunter N, H\u00e9rault O, Mazurier F. Hypoxia and hypoxia-inducible factors in leukemias. Front Oncol. 2016;6:41.","journal-title":"Front Oncol"},{"key":"1280_CR21","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nrc3064","volume":"11","author":"WR Wilson","year":"2011","unstructured":"Wilson WR, Hay MP. Targeting hypoxia in cancer therapy. Nat Rev Cancer. 2011;11:393\u2013410.","journal-title":"Nat Rev Cancer"},{"key":"1280_CR22","doi-asserted-by":"publisher","first-page":"13464","DOI":"10.18632\/oncotarget.7229","volume":"7","author":"E Paolicchi","year":"2016","unstructured":"Paolicchi E, Gemignani F, Krstic-Demonacos M, Dedhar S, Mutti L, Landi S. Targeting hypoxic response for cancer therapy. Oncotarget. 2016;7:13464\u201378.","journal-title":"Oncotarget."},{"key":"1280_CR23","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nrm3311","volume":"13","author":"DG Hardie","year":"2012","unstructured":"Hardie DG, Ross FA, Hawley SA. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol. 2012;13:251\u201362.","journal-title":"Nat Rev Mol Cell Biol."},{"key":"1280_CR24","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1146\/annurev-pharmtox-010611-134537","volume":"52","author":"K Inoki","year":"2012","unstructured":"Inoki K, Kim J, Guan KL. AMPK and mTOR in cellular energy homeostasis and drug targets. Annu Rev Pharmacol Toxicol. 2012;52:381\u2013400.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"1280_CR25","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.cmet.2016.03.008","volume":"23","author":"RJ Kishton","year":"2016","unstructured":"Kishton RJ, Barnes CE, Nichols AG, Cohen S, Gerriets VA, Siska PJ, et al. AMPK is essential to balance glycolysis and mitochondrial metabolism to control T-ALL cell stress and survival. Cell Metab. 2016;23:649\u201362.","journal-title":"Cell Metab"},{"key":"1280_CR26","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nature11066","volume":"485","author":"SM Jeon","year":"2012","unstructured":"Jeon SM, Chandel NS, Hay N. AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress. Nature. 2012;485:661\u20135.","journal-title":"Nature."},{"key":"1280_CR27","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.stem.2015.08.019","volume":"17","author":"Y Saito","year":"2015","unstructured":"Saito Y, Chapple RH, Lin A, Kitano A, Nakada D. AMPK protects leukemia-initiating cells in myeloid leukemias from metabolic stress in the bone marrow. Cell Stem Cell. 2015;17:585\u201396.","journal-title":"Cell Stem Cell"},{"key":"1280_CR28","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.cmet.2012.12.001","volume":"17","author":"B Faubert","year":"2013","unstructured":"Faubert B, Boily G, Izreig S, Griss T, Samborska B, Dong Z, et al. AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in vivo. Cell Metab. 2013;17:113\u201324.","journal-title":"Cell Metab"},{"key":"1280_CR29","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/leu.2011.269","volume":"26","author":"C Grimaldi","year":"2012","unstructured":"Grimaldi C, Chiarini F, Tabellini G, Ricci F, Tazzari PL, Battistelli M, et al. AMP-dependent kinase\/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications. Leukemia. 2012;26:91\u2013100.","journal-title":"Leukemia."},{"key":"1280_CR30","doi-asserted-by":"publisher","first-page":"7507","DOI":"10.1158\/0008-5472.CAN-09-2994","volume":"69","author":"HA Hirsch","year":"2009","unstructured":"Hirsch HA, Iliopoulos D, Tsichlis PN, Struhl K. Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission. Cancer Res. 2009;69:7507\u201311.","journal-title":"Cancer Res"},{"key":"1280_CR31","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.7150\/jca.19873","volume":"8","author":"Y Yi","year":"2017","unstructured":"Yi Y, Gao L, Wu M, Ao J, Zhang C, Wang X, et al. Metformin sensitizes leukemia cells to vincristine via activation of AMP-activated protein kinase. J Cancer. 2017;8:2636\u201342.","journal-title":"J Cancer"},{"key":"1280_CR32","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrm.2017.95","volume":"19","author":"S Herzig","year":"2018","unstructured":"Herzig S, Shaw RJ. AMPK: guardian of metabolism and mitochondrial homeostasis. Nat Rev Mol Cell Biol. 2018;19:121\u201335.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1280_CR33","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3389\/fimmu.2018.00040","volume":"9","author":"S Sormendi","year":"2018","unstructured":"Sormendi S, Wielockx B. Hypoxia pathway proteins as central mediators of metabolism in the mumor cells and their microenvironment. Front Immunol. 2018;9:40.","journal-title":"Front Immunol"},{"key":"1280_CR34","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1080\/14728222.2018.1487401","volume":"22","author":"I Nepstad","year":"2018","unstructured":"Nepstad I, Hatfield KJ, Aaseb\u00f8 E, Hernandez-Valladares M, Brenner AK, Bartaula-Brevik S, et al. Two acute myeloid leukemia patient subsets are identified based on the constitutive PI3K-Akt-mTOR signaling of their leukemic cells; a functional, proteomic, and transcriptomic comparison. Expert Opin Ther Targets. 2018;22:639\u201353.","journal-title":"Expert Opin Ther Targets"},{"key":"1280_CR35","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nm.2091","volume":"16","author":"MR Janes","year":"2010","unstructured":"Janes MR, Limon JJ, So L, Chen J, Lim RJ, Chavez MA, et al. Effective and selective targeting of leukemia cells using a TORC1\/2 kinase inhibitor. Nat Med. 2010;16:205\u201313.","journal-title":"Nat Med"},{"key":"1280_CR36","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40591-015-0040-8","volume":"3","author":"L Fransecky","year":"2015","unstructured":"Fransecky L, Mochmann LH, Baldus CD. Outlook on PI3K\/AKT\/mTOR inhibition in acute leukemia. Mol Cell Ther. 2015;3:2.","journal-title":"Mol Cell Ther"},{"key":"1280_CR37","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13148-018-0516-x","volume":"10","author":"K Shah","year":"2018","unstructured":"Shah K, Moharram SA, Kazi JU. Acute leukemia cells resistant to PI3K\/mTOR inhibition display upregulation of P2RY14 expression. Clin Epigenetics. 2018;10:83.","journal-title":"Clin Epigenetics"},{"key":"1280_CR38","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/nrc2501","volume":"8","author":"BG Wouters","year":"2008","unstructured":"Wouters BG, Koritzinsky M. Hypoxia signalling through mTOR and the unfolded protein response in cancer. Nat Rev Cancer. 2008;8:851\u201364.","journal-title":"Nat Rev Cancer"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-019-1280-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13046-019-1280-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-019-1280-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T23:19:08Z","timestamp":1592522348000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-019-1280-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,20]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1280"],"URL":"https:\/\/doi.org\/10.1186\/s13046-019-1280-2","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,20]]},"assertion":[{"value":"5 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Research Institute Animal Ethics Committee of West China Second University Hospital (Chengdu, China). All animal care was in compliance with the guidelines established by the internal Institutional Animal Care and Use Committee and Ethics Committee guidelines of Sichuan University.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"269"}}